Showing results (2081-2090 of 4,275) with videos related to
Sort By:
Pageof 428
Cancer Discovery|June 29, 2024
The History of Chromosomal Instability in Genome-Doubled TumorsToby M Baker, Siqi Lai, Andrew R Lynch, et al.Cancer Discovery|April 8, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer CellsGabriele Picco, Yanhua Rao, Angham Al Saedi, et al.Cancer Discovery|April 2, 2024
Phosphocreatine Promotes Epigenetic Reprogramming to Facilitate Glioblastoma Growth Through Stabilizing BRD2Lishu Chen, Qinghui Qi, Xiaoqing Jiang, et al.Cancer Discovery|April 9, 2024
ZNF397 Deficiency Triggers TET2-Driven Lineage Plasticity and AR-Targeted Therapy Resistance in Prostate CancerYaru Xu, Yuqiu Yang, Zhaoning Wang, et al.Cancer Discovery|April 10, 2024
Artificial Intelligence in Oncology: Current Landscape, Challenges, and Future DirectionsWilliam Lotter, Michael J Hassett, Nikolaus Schultz, et al.Cancer Discovery|April 4, 2024
Phase-Separated Biomolecular Condensation in Cancer: New Horizons and Next FrontiersTrever G BivonaCancer Discovery|August 28, 2024
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast CancerJitendra K Meena, Jarey H Wang, Nicholas J Neill, et al.Cancer Discovery|September 9, 2024
Increased RNA and Protein Degradation Is Required for Counteracting Transcriptional Burden and Proteotoxic Stress in Human Aneuploid CellsMarica Rosaria Ippolito, Johanna Zerbib, Yonatan Eliezer, et al.Cancer Discovery|September 9, 2024
Zongertinib (BI 1810631), an Irreversible HER2 TKI, Spares EGFR Signaling and Improves Therapeutic Response in Preclinical Models and Patients with HER2-Driven CancersBirgit Wilding, Lydia Woelflingseder, Anke Baum, et al.Cancer Discovery|September 4, 2024
If You Build It, Patients with Rare Cancers Will Come: A Successful Clinical Trial in Relapsed and Refractory JMMLNana Adjoa Ben-Crentsil, Eric PadronPageof 428